Comments
Loading...

Exact Sciences Analyst Ratings

EXASNASDAQ
Logo brought to you by Benzinga Data
$58.08
1.522.69%
At close: -
$57.88
-0.20-0.34%
After Hours: 4:14 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$90.00
Lowest Price Target1
$54.00
Consensus Price Target1
$72.28

Exact Sciences Analyst Ratings and Price Targets | NASDAQ:EXAS | Benzinga

Exact Sciences Corp has a consensus price target of $72.28 based on the ratings of 28 analysts. The high is $90 issued by Bernstein on October 30, 2024. The low is $54 issued by RBC Capital on May 2, 2025. The 3 most-recent analyst ratings were released by Barclays, RBC Capital, and Evercore ISI Group on May 2, 2025, respectively. With an average price target of $65 between Barclays, RBC Capital, and Evercore ISI Group, there's an implied 12.30% upside for Exact Sciences Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Feb
0
0
0
0
Mar
3
Apr
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
RBC Capital
Evercore ISI Group
Baird
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Exact Sciences

Buy NowGet Alert
05/02/2025Buy Now29.58%Barclays
Luke Sergott50%
$55 → $75MaintainsOverweightGet Alert
05/02/2025Buy Now-6.7%RBC Capital
Gerard Cassidy72%
$52 → $54MaintainsSector PerformGet Alert
05/02/2025Buy Now14.03%Evercore ISI Group
Vijay Kumar51%
$60 → $66MaintainsOutperformGet Alert
05/02/2025Buy Now24.4%Baird
Catherine Schulte66%
$69 → $72MaintainsOutperformGet Alert
04/11/2025Buy Now3.66%Guggenheim
Subbu Nambi41%
$60 → $60ReiteratesBuy → BuyGet Alert
04/10/2025Buy Now-4.98%Barclays
Luke Sergott50%
$65 → $55MaintainsOverweightGet Alert
04/10/2025Buy Now3.66%Mizuho
Anthony Petrone63%
→ $60Initiates → OutperformGet Alert
03/13/2025Buy Now-10.16%RBC Capital
Gerard Cassidy72%
→ $52Initiates → Sector PerformGet Alert
02/26/2025Buy Now20.94%Piper Sandler
David Westenberg58%
$75 → $70MaintainsOverweightGet Alert
02/24/2025Buy Now26.12%Scotiabank
Sung Ji Nam44%
$70 → $73MaintainsSector OutperformGet Alert
02/20/2025Buy Now12.3%B of A Securities
Derik De Bruin84%
$72 → $65MaintainsBuyGet Alert
02/20/2025Buy Now12.3%Barclays
Luke Sergott50%
$70 → $65MaintainsOverweightGet Alert
01/23/2025Buy Now20.94%Barclays
Luke Sergott50%
→ $70Initiates → OverweightGet Alert
01/13/2025Buy Now12.3%Benchmark
Bruce Jackson40%
$65 → $65ReiteratesBuy → BuyGet Alert
12/13/2024Buy Now24.4%B of A Securities
Derik De Bruin84%
$75 → $72MaintainsBuyGet Alert
11/26/2024Buy Now48.58%TD Cowen
Dan Brennan62%
$82 → $86MaintainsBuyGet Alert
11/26/2024Buy Now29.58%BTIG
Mark Massaro72%
$65 → $75MaintainsBuyGet Alert
11/11/2024Buy Now29.58%Piper Sandler
David Westenberg58%
$85 → $75MaintainsOverweightGet Alert
11/06/2024Buy Now29.58%Citigroup
Patrick Donnelly80%
$80 → $75MaintainsBuyGet Alert
11/06/2024Buy Now46.86%Jefferies
Brandon Couillard23%
$84 → $85MaintainsBuyGet Alert
11/06/2024Buy Now12.3%BTIG
Mark Massaro72%
$82 → $65MaintainsBuyGet Alert
11/06/2024Buy Now15.76%Stifel
Daniel Arias78%
$82 → $67MaintainsBuyGet Alert
11/06/2024Buy Now29.58%Canaccord Genuity
Kyle Mikson36%
$95 → $75MaintainsBuyGet Alert
11/06/2024Buy Now41.67%TD Cowen
Dan Brennan62%
$90 → $82MaintainsBuyGet Alert
11/06/2024Buy Now12.3%Goldman Sachs
Matthew Sykes63%
$75 → $65MaintainsBuyGet Alert
11/06/2024Buy Now3.66%Evercore ISI Group
Vijay Kumar51%
$80 → $60MaintainsOutperformGet Alert
11/06/2024Buy Now12.3%Craig-Hallum
Alex Nowark65%
$82 → $65MaintainsBuyGet Alert
11/06/2024Buy Now12.3%Benchmark
Bruce Jackson40%
$67 → $65MaintainsBuyGet Alert
11/06/2024Buy Now15.76%Baird
Catherine Schulte66%
$70 → $67MaintainsOutperformGet Alert
10/30/2024Buy Now55.49%Bernstein
Eve Burstein45%
$75 → $90MaintainsOutperformGet Alert
10/29/2024Buy Now64.13%Canaccord Genuity
Kyle Mikson36%
$75 → $95MaintainsBuyGet Alert
10/01/2024Buy Now38.22%Evercore ISI Group
Vijay Kumar51%
$72 → $80MaintainsOutperformGet Alert
09/26/2024Buy NowRaymond James
Andrew Cooper53%
Reiterates → Market PerformGet Alert
09/13/2024Buy Now29.58%Canaccord Genuity
Kyle Mikson36%
$75 → $75MaintainsBuyGet Alert
09/12/2024Buy Now46.86%Piper Sandler
David Westenberg58%
$75 → $85MaintainsOverweightGet Alert
08/27/2024Buy Now29.58%Wells Fargo
Brandon Couillard23%
→ $75Initiates → OverweightGet Alert
08/01/2024Buy Now15.76%Benchmark
Bruce Jackson40%
$91 → $67MaintainsBuyGet Alert
08/01/2024Buy Now41.67%Stifel
Daniel Arias78%
$100 → $82MaintainsBuyGet Alert
07/17/2024Buy Now29.58%Goldman Sachs
Matthew Sykes63%
$88 → $75MaintainsBuyGet Alert
07/02/2024Buy Now24.4%Evercore ISI Group
Vijay Kumar51%
$80 → $72MaintainsOutperformGet Alert
06/27/2024Buy Now20.94%BTIG
Mark Massaro72%
$80 → $70MaintainsBuyGet Alert
06/27/2024Buy Now20.94%Scotiabank
Sung Ji Nam44%
→ $70Initiates → Sector OutperformGet Alert
06/26/2024Buy Now20.94%BTIG
Mark Massaro72%
$80 → $70MaintainsBuyGet Alert
05/09/2024Buy Now38.22%BTIG
Mark Massaro72%
$85 → $80MaintainsBuyGet Alert
05/09/2024Buy Now46.86%Canaccord Genuity
Kyle Mikson36%
$90 → $85MaintainsBuyGet Alert
05/09/2024Buy Now38.22%Citigroup
Patrick Donnelly80%
$100 → $80MaintainsBuyGet Alert
04/03/2024Buy Now72.77%Citigroup
Patrick Donnelly80%
→ $100MaintainsBuyGet Alert
02/22/2024Buy Now55.49%Canaccord Genuity
Kyle Mikson36%
$100 → $90MaintainsBuyGet Alert
01/02/2024Buy Now57.22%Benchmark
Bruce Jackson40%
→ $91UpgradeHold → BuyGet Alert
12/14/2023Buy Now55.49%Guggenheim
Subbu Nambi41%
→ $90Initiates → BuyGet Alert
12/13/2023Buy NowWolfe Research
Doug Schenkel71%
Initiates → OutperformGet Alert
11/03/2023Buy Now55.49%Goldman Sachs
Matthew Sykes63%
$100 → $90MaintainsBuyGet Alert
10/16/2023Buy Now38.22%Piper Sandler
David Westenberg58%
$90 → $80MaintainsOverweightGet Alert
10/10/2023Buy Now55.49%Piper Sandler
David Westenberg58%
→ $90UpgradeNeutral → OverweightGet Alert
09/28/2023Buy Now43.4%Bernstein
Eve Burstein45%
→ $83Initiates → OutperformGet Alert
08/08/2023Buy Now55.49%Piper Sandler
David Westenberg58%
$80 → $90MaintainsNeutralGet Alert
08/03/2023Buy Now90.05%Jefferies
Brandon Couillard23%
$100 → $110MaintainsBuyGet Alert
08/02/2023Buy Now55.49%Credit Suisse
Dan Leonard54%
$75 → $90MaintainsNeutralGet Alert
08/02/2023Buy Now109.05%Baird
Catherine Schulte66%
$99 → $121MaintainsOutperformGet Alert
08/02/2023Buy NowBenchmark
Bruce Jackson40%
DowngradeBuy → HoldGet Alert
07/24/2023Buy Now90.05%Goldman Sachs
Matthew Sykes63%
$85 → $110MaintainsBuyGet Alert
07/21/2023Buy Now90.05%Goldman Sachs
Matthew Sykes63%
$85 → $110MaintainsBuyGet Alert
06/23/2023Buy Now98.69%Canaccord Genuity
Kyle Mikson36%
$92 → $115MaintainsBuyGet Alert
06/22/2023Buy Now124.6%Citigroup
Patrick Donnelly80%
$100 → $130MaintainsBuyGet Alert
06/22/2023Buy Now65.86%Benchmark
Bruce Jackson40%
→ $96ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now46.86%Stifel
Daniel Arias78%
→ $85ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now58.95%Canaccord Genuity
Kyle Mikson36%
→ $92ReiteratesBuy → BuyGet Alert
06/07/2023Buy Now72.77%Jefferies
Brandon Couillard23%
$82 → $100MaintainsBuyGet Alert
05/11/2023Buy Now72.77%Citigroup
Patrick Donnelly80%
$90 → $100MaintainsBuyGet Alert
05/10/2023Buy Now41.67%Jefferies
Brandon Couillard23%
$72 → $82MaintainsBuyGet Alert
05/10/2023Buy Now52.04%B of A Securities
Derik De Bruin84%
$80 → $88MaintainsBuyGet Alert
05/10/2023Buy Now29.58%Credit Suisse
Dan Leonard54%
$70 → $75MaintainsNeutralGet Alert
05/10/2023Buy Now71.04%Baird
Catherine Schulte66%
$92 → $99MaintainsOutperformGet Alert
05/10/2023Buy Now46.86%Craig-Hallum
Alex Nowark65%
$55 → $85UpgradeHold → BuyGet Alert
05/05/2023Buy Now26.12%UBS
Elizabeth Garcia70%
→ $73Initiates → NeutralGet Alert
03/15/2023Buy Now34.76%Benchmark
Bruce Jackson40%
$54 → $78MaintainsBuyGet Alert
03/09/2023Buy Now55.49%Citigroup
Patrick Donnelly80%
$70 → $90UpgradeNeutral → BuyGet Alert
03/03/2023Buy Now20.94%Piper Sandler
David Westenberg58%
$50 → $70MaintainsNeutralGet Alert
02/22/2023Buy Now31.31%Cowen & Co.
Dan Brennan62%
$56 → $76MaintainsOutperformGet Alert
02/22/2023Buy Now58.95%Baird
Catherine Schulte66%
$89 → $92MaintainsOutperformGet Alert
02/22/2023Buy Now38.22%BTIG
Mark Massaro72%
$85 → $80MaintainsBuyGet Alert
02/22/2023Buy Now29.58%Canaccord Genuity
Kyle Mikson36%
$70 → $75MaintainsBuyGet Alert
02/22/2023Buy Now20.94%Citigroup
Patrick Donnelly80%
$35 → $70MaintainsNeutralGet Alert
02/22/2023Buy Now20.94%Credit Suisse
Dan Leonard54%
→ $70Reiterates → NeutralGet Alert
02/10/2023Buy Now20.94%Credit Suisse
Dan Leonard54%
$50 → $70DowngradeOutperform → NeutralGet Alert
01/18/2023Buy NowRaymond James
Andrew Cooper53%
DowngradeOutperform → Market PerformGet Alert
01/12/2023Buy Now29.58%SVB Leerink
Puneet Souda57%
$70 → $75MaintainsOutperformGet Alert
01/06/2023Buy Now20.94%SVB Leerink
Puneet Souda57%
$60 → $70MaintainsOutperformGet Alert
12/16/2022Buy Now20.94%Jefferies
Brandon Couillard23%
→ $70MaintainsBuyGet Alert
11/14/2022Buy Now-13.61%Piper Sandler
David Westenberg58%
$40 → $50MaintainsNeutralGet Alert
11/08/2022Buy Now3.66%Raymond James
Andrew Cooper53%
$70 → $60MaintainsOutperformGet Alert
11/07/2022Buy Now12.3%BTIG
Mark Massaro72%
$70 → $65MaintainsBuyGet Alert
10/19/2022Buy NowCraig-Hallum
Alexander Nowak53%
DowngradeBuy → HoldGet Alert
08/25/2022Buy Now-4.98%Credit Suisse
Dan Leonard54%
→ $55Initiates → OutperformGet Alert
08/17/2022Buy Now-30.89%Piper Sandler
David Westenberg58%
$50 → $40MaintainsOverweightGet Alert
08/03/2022Buy Now3.66%Craig-Hallum
Alex Nowark65%
$81 → $60MaintainsBuyGet Alert
08/03/2022Buy Now15.76%Cowen & Co.
Dan Brennan62%
$83 → $67MaintainsOutperformGet Alert
08/03/2022Buy Now20.94%BTIG
Mark Massaro72%
$100 → $70MaintainsBuyGet Alert
08/03/2022Buy Now29.58%Baird
Catherine Ramsey49%
$90 → $75MaintainsOutperformGet Alert
08/03/2022Buy Now-13.61%Citigroup
Patrick Donnelly80%
$65 → $50MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Exact Sciences (EXAS) stock?

A

The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Barclays on May 2, 2025. The analyst firm set a price target for $75.00 expecting EXAS to rise to within 12 months (a possible 29.58% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Exact Sciences (EXAS)?

A

The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by Barclays, and Exact Sciences maintained their overweight rating.

Q

When was the last upgrade for Exact Sciences (EXAS)?

A

The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.

Q

When was the last downgrade for Exact Sciences (EXAS)?

A

The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.

Q

When is the next analyst rating going to be posted or updated for Exact Sciences (EXAS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.

Q

Is the Analyst Rating Exact Sciences (EXAS) correct?

A

While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a maintained with a price target of $55.00 to $75.00. The current price Exact Sciences (EXAS) is trading at is $57.88, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch